Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propacetamol for PONV in high-risk female patients
NCT02116257Completed
- Sponsor
- Yonsei University
- Start
- Nov 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propacetamol in postoperative nausea and vomiting (PONV) and postoperative pain, sponsored by Yonsei University. Primary endpoint: Incidence of postoperative nausea and vomiting at 24 hours. Started Nov 2013; status: completed.
02
Drugs
propacetamol
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT02116257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116257.